Cargando…

Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children

Childhood obesity when associated with serum lipoprotein changes triggers atherosclerosis. Evidences suggest that the atherosclerotic process begins in childhood and that the extent of early atherosclerosis of the aorta and coronary arteries can be associated with lipoprotein levels and obesity. Fur...

Descripción completa

Detalles Bibliográficos
Autores principales:	D'Adamo, Ebe, Guardamagna, Ornella, Chiarelli, Francesco, Bartuli, Andrea, Liccardo, Daniela, Ferrari, Federica, Nobili, Valerio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309297/ https://www.ncbi.nlm.nih.gov/pubmed/25663838 http://dx.doi.org/10.1155/2015/912047

Ejemplares similares

The Liver in Children With Metabolic Syndrome
por: D'Adamo, Ebe, et al.
Publicado: (2019)

Prevalence of dyslipidemia, atherogenic and cardiovascular risk in overweight and obese adolescents
por: de Andrades, Clara dos Santos, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
por: Scapaticci, Serena, et al.
Publicado: (2021)

Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013)

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
por: Musunuru, Kiran
Publicado: (2010)

Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk
por: Vekic, Jelena, et al.
Publicado: (2023)

Serum Levels of Receptors for Advanced Glycation End Products in Normal-Weight and Obese Children Born Small and Large for Gestational Age
por: Chiavaroli, Valentina, et al.
Publicado: (2012)

Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
por: Kutkiene, Sandra, et al.
Publicado: (2018)

Anthropometric features as predictors of atherogenic dyslipidemia and cardiovascular risk in a large population of school-aged children
por: Furtado, José M., et al.
Publicado: (2018)

Search for genetic factors predisposing to atherogenic dyslipidemia
por: Yip, Agustin G, et al.
Publicado: (2003)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
por: D’Adamo, Ebe, et al.
Publicado: (2011)

Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients
por: Rocha, Milagros, et al.
Publicado: (2013)

Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
por: Roy, Probin Kr, et al.
Publicado: (2023)

Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia
por: Frayn, Keith, et al.
Publicado: (2012)

Hibernating brown bears are protected against atherogenic dyslipidemia
por: Giroud, Sylvain, et al.
Publicado: (2021)

Assessment of Dyslipidemia, Lipid Ratios, and Atherogenic Indices as Cardiovascular Risk Factors in Prediabetic and Diabetic Subjects
por: Rathi, Himani, et al.
Publicado: (2022)

Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
por: Guasch, Alba, et al.
Publicado: (2012)

Correction: Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients
por: Rocha, Milagros, et al.
Publicado: (2013)

Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
por: Kumar, Ajoy, et al.
Publicado: (2010)

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor
por: Alibasic, Esad, et al.
Publicado: (2015)

Glycative Stress, Glycated Hemoglobin, and Atherogenic Dyslipidemia in Patients with Hyperlipidemia
por: Yao, Chien-An, et al.
Publicado: (2023)

The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape
por: Bage, Isaac J, et al.
Publicado: (2023)

Skipping Breakfast Is Associated with an Atherogenic Lipid Profile in Overweight and Obese Prepubertal Children
por: Blasetti, A., et al.
Publicado: (2020)

Role of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?
por: Munigoti, Srinivasa P., et al.
Publicado: (2014)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria
por: Olamoyegun, Michael Adeyemi, et al.
Publicado: (2016)

Central Role of Fatty Liver in the Pathogenesis of Insulin Resistance in Obese Adolescents
por: D'Adamo, Ebe, et al.
Publicado: (2010)

Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population
por: Liu, Chiu-Shong, et al.
Publicado: (2010)

Waist Circumference as a Preventive Tool of Atherogenic Dyslipidemia and Obesity-Associated Cardiovascular Risk in Young Adults Males: A Cross-Sectional Pilot Study
por: Hernández-Reyes, Alberto, et al.
Publicado: (2020)

Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
por: Halcox, Julian P., et al.
Publicado: (2017)

Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss
por: Feinman, Richard D, et al.
Publicado: (2006)

Prevalence and Predictors of Atherogenic Serum Lipoprotein Dyslipidemia in Women with Obstructive Sleep Apnea
por: Xia, Yunyan, et al.
Publicado: (2017)

Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs
por: Romandini, Alessandra, et al.
Publicado: (2023)

Association between Wakeup Frequency at Night and Atherogenic Dyslipidemia: Evidence for Sex Differences
por: Yao, Chien-An, et al.
Publicado: (2023)

Insulin Resistance, Dyslipidemia and Cardiovascular Changes in a Group of Obese Children
por: Pires, António, et al.
Publicado: (2015)

The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease
por: Alkhouri, Naim, et al.
Publicado: (2014)

Lutein levels in arterial cord blood correlate with neurotrophic calcium binding S100B protein in healthy preterm and term newborns
por: Picone, Simonetta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0nlcfetb6e0lhdr3ijvns3ojlf